Emsurg Bioscience India Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 12-07-2024
- Paid Up Capital ₹ 1.00 M
as on 12-07-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 237.76%
(FY 2022)
- Profit 42.02%
(FY 2022)
- Ebitda 91.85%
(FY 2022)
- Net Worth 9.27%
(FY 2022)
- Total Assets 63.54%
(FY 2022)
About Emsurg Bioscience India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Priyanka Acharyya, Pratim Ganguly, Ritobroto Mukherjee, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100WB2020PTC238797
- Company No.
238797
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Aug 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Emsurg Bioscience India?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kunal Mukherjee  | Director | 11-Aug-2020 | Current |
| Priyanka Acharyya | Director | 11-Aug-2020 | Current |
| Pratim Ganguly | Director | 24-Mar-2023 | Current |
| Ritobroto Mukherjee | Director | 11-Aug-2020 | Current |
| Partha Gupta | Additional Director | 02-Nov-2020 | Current |
Financial Performance of Emsurg Bioscience India.
Emsurg Bioscience India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 237.76% increase. The company also saw a substantial improvement in profitability, with a 42.02% increase in profit. The company's net worth moved up by a moderate rise of 9.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Emsurg Bioscience India?
In 2022, Emsurg Bioscience India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Emsurg Healthcare (India) Private LimitedActive 14 years 10 monthsPriyanka Acharyya, Ritobroto Mukherjee and 1 more are mutual person
Krishnapur Nabadiganta Hospital Private LimitedActive 2 years 9 monthsPratim Ganguly is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Emsurg Bioscience India?
Emsurg Bioscience India has a workforce of 20 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Emsurg Bioscience India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emsurg Bioscience India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
